Episode 101: Target doses for CHF - is there collateral damage when shooting for targets?

Submitted by admin on Tue, 2010-10-19 17:37

In episode 101, your friendly centurions, James and Mike, take a shot at the evidence around target doses for drugs in CHF and find the data is not as compelling as one might think. They discuss the approach of making sure we don't cause side effects trying to get patients to these targets.

The full content of this Podcast, including the audio file, is available to Premium Members only. Click to find out the benefits of having a Premium Membership.

Why Get A Premium Membership ?

Comments

Great podcast. It's always

Submitted by DocRock (not verified) on Thu, 2010-10-21 22:27.

Great podcast. It's always interesting to hear what "target doses" we "must" get patients to. It's even better to hear the actual evidence. I'd like to have someone who swears by the target doses explain why it is a must based on the actual data. Thanks!

not sure if this should be in

Submitted by DavidSandhu (not verified) on Mon, 2010-11-15 03:26.

not sure if this should be in the comment area, but link 4 and 5 both point to the article in lancet. thanks for all the links :)

Post new comment

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.